APR 21, 2021 8:00 AM PDT

Human T Cells Can't Recognize COVID Mutants

WRITTEN BY: Tara Fernandez

Genetic variants of the SARS-CoV-2 virus have emerged and tightened their grip on global communities as the pandemic rages on. In the United States, variants such as B.1.1.7, B.1.351, and P.1have been classified by the CDC as “variants of concern”—flagged for their ability to cause more severe disease and undercut the effectiveness of vaccines, treatments, and diagnostics.

Now, a recent study has revealed how these mutants are also able to evade recognition by T cells. 

Virally-infected cells use class 1 major histocompatibility complex proteins (or MHCs) to display fragments of viral peptides on the cell surface. Immune T cells circulate the body on the hunt for pathogenic intruders. When they recognize a suspicious-looking peptide bound to an MHC molecule, the T cell is activated, releasing cytotoxic factors to destroy the infected cell and restrict the pathogen’s ability to do more damage.

However, viruses are adaptable and have ways of avoiding T cell detection, such as by blocking MHC molecules bearing viral peptides from getting to the cell surface.

The research team studied how SARS-CoV-2 mutations affected T cell recognition compared to the wild-type virus. "We found that several variants resulted in complete loss of responsiveness to the T cell lines evaluated," wrote the authors of the study, uploaded to the preprint server bioRxiv.

The scientists hypothesize a number of mechanisms by which the mutants are resisting elimination by T cells including potential differences in antigen-presenting or the mutants’ ability to interfere with the recognition of the MHC-bound peptide by the T cell receptor.

To confirm these findings, the team exposed viral peptides from variants to T cells isolated from convalescent donors. They found that these T cells showed markedly decreased functionality when it came to recognizing viral peptides as pathogenic.

"Our findings demonstrate the potential for T-cell evasion and highlight the need for ongoing surveillance for variants capable of escaping T-cell as well as humoral immunity," wrote the authors.

 



Source: BioRxiv.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JAN 20, 2021
Immunology
Gut Bacteria's Poison Arrows Exposed
JAN 20, 2021
Gut Bacteria's Poison Arrows Exposed
Bacteria armed with toxin bombs and excruciating abdominal pains caused by raging inflammation in the gut. While the cau ...
MAR 23, 2021
Immunology
Assay Detects Antibodies in Asymptomatic COVID Carriers
MAR 23, 2021
Assay Detects Antibodies in Asymptomatic COVID Carriers
It is estimated that around one in five people infected with SARS-CoV-2 will not show any infection symptoms. Some of th ...
APR 01, 2021
Immunology
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
APR 01, 2021
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
Cancer researchers have developed a therapeutic vaccine for melanoma, a deadly form of skin cancer. Instead of protectin ...
MAY 06, 2021
Immunology
COVID Vaccines Don't Protect Everyone
MAY 06, 2021
COVID Vaccines Don't Protect Everyone
New research has revealed that COVID-19 vaccines may not work as effectively in those whose immune systems have been neg ...
JUN 03, 2021
Immunology
Inhalable Anti-COVID Nanobodies Show Promising Results in Hamsters
JUN 03, 2021
Inhalable Anti-COVID Nanobodies Show Promising Results in Hamsters
Nanobodies are small fragments of monoclonal antibodies that from a therapeutic perspective are more stable and cheaper ...
JUN 08, 2021
Immunology
Is the Pfizer-BioNtech Vaccine Variant-Resistant?
JUN 08, 2021
Is the Pfizer-BioNtech Vaccine Variant-Resistant?
Genetic variants of SARS-CoV-2 have emerged over the course of the pandemic, threatening public health efforts to limit ...
Loading Comments...